Journal of labelled compounds & radiopharmaceuticals | 2021

Fully automated production of the fibroblast activation protein radiotracer [18 F]FAPI-74.

 
 
 
 
 
 

Abstract


We report herein an efficient and fully automated protocol for the radiosynthesis of [18 F]FAPI-74, a new positron emission tomography (PET) radiopharmaceutical for in vivo detection of the fibroblast activation protein. [18 F]FAPI-74 was synthesized via a rapid [18 F]aluminum fluoride coordination reaction, which was first developed on the flexible GE TRACERLab FX2N (FXN) platform and later translated to the cassette-based module Trasis AllInOne (AIO). The results obtained with both modules were comparable in terms of yield and reproducibility. Automation of [18 F]FAPI-74 radiosynthesis on the FXN was carried out in 35\u2009min with a radiochemical yield (RCY) of 18.5\u2009±\u20092.5% (n\u2009=\u20095, relative to starting [18 F]fluoride). Method transfer to the AIO platform following minor optimizations allowed for the production of [18 F]FAPI-74 in an isolated RCY of 20\u2009±\u20092.5% [n\u2009=\u20093] with an overall synthesis time of 40\u2009min. The radiochemical purity was greater than 95% for [18 F]FAPI-74, obtained from both modules. Overall, the protocol reliably provides a sterile and pyrogen-free good manufacturing practice (GMP) compliant product of [18 F]FAPI-74 suitable for clinical PET imaging.

Volume None
Pages None
DOI 10.1002/jlcr.3926
Language English
Journal Journal of labelled compounds & radiopharmaceuticals

Full Text